Radiotherapy Market Share and Size Analysis

The market size of the Radiotherapy industry was estimated to be USD 6.2 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2030, reaching a value of USD 9.44 billion by 2030.

Radiotherapy, a vital component of cancer treatment, has witnessed significant growth in recent years. This upward trajectory is expected to continue, driven by advancements in technology, increasing prevalence of cancer cases, and rising awareness about the benefits of radiotherapy.

The forecasted growth in the Radiotherapy market is attributed to several factors. Firstly, the continuous development of innovative radiotherapy techniques and equipment, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), has enhanced treatment precision and reduced side effects. These advancements have significantly improved patient outcomes and increased the adoption of radiotherapy as a preferred treatment option.

Secondly, the rising incidence of cancer globally has created a substantial demand for effective treatment methods. Radiotherapy, with its ability to target cancer cells while minimizing damage to healthy tissues, has emerged as a crucial therapeutic approach. The increasing prevalence of various types of cancer, including lung, breast, prostate, and colorectal cancer, is expected to drive the demand for radiotherapy in the coming years.

Furthermore, growing awareness among patients and healthcare professionals about the benefits of radiotherapy has contributed to its market growth. The recognition of radiotherapy as a safe and effective treatment option, coupled with the availability of advanced facilities and skilled healthcare professionals, has bolstered its acceptance and utilization.

Geographically, North America currently dominates the Radiotherapy market, owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and a large patient pool. However, the Asia-Pacific region is anticipated to witness the highest growth rate during the forecast period. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about cancer treatment options.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3367

KEY MARKET SEGMENTATION:

By Type

  • Product
  • Service

By Technology

  • External Beam Radiotherapy
    • Linear Accelerators
      • Conventional Linear Accelerators
      • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
      • Gamma Knife
      • CyberKnife
      • TomoTherapy
    • Conventional Cobalt-60 Teletherapy Units
    • Particle Therapy Systems
      • Cyclotrons
      • Synchrotrons
      • Synchrocyclotron
    • Internal Beam Radiotherapy/Brachytherapy
      • Seeds
      • Afterloaders
      • Applicators
      • IORT Systems
    • Systemic Radiotherapy
      • lobenguane (I-131)
      • Samarium-153
      • Rhenium-186
      • Other Systemic Radiotherapy Products

By Application

  • External Beam Radiotherapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head and Neck Cancer
    • Colorectal Cancer
    • Other Cancers
  • Internal Beam Radiotherapy/Brachytherapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Cervical Cancer
    • Penile Cancer
    • Other Cancers

By Procedure

  • External Beam Radiotherapy
    • Image-guided Radiotherapy
    • Intensity-modulated Radiotherapy
    • Stereotactic Therapy
    • Particle Therapy
    • 3D Conformal Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
    • High-dose-rate Brachytherapy
    • Low-dose-rate Brachytherapy
    • Pulsed-dose-rate Brachytherapy
  • Systemic Radiotherapy
  • Intravenous Radiotherapy
  • Oral Radiotherapy
  • Instillation Radiotherapy

By End User

  • Hospitals
  • Independent Radiotherapy Centers.

Some of the major key players are as follows: Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Inc, Hitachi Ltd, iCAD, inc, IsoRay, Inc, Mevioi Medical Systems, Inc, Panacea Medical Technologies Pvt. Ltd, P-cure Ltd, and ZEISS Group, and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand — Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND),

Website: https://www.snsinsider.com